Valuation: Celltrion, Inc.

Capitalization 41,090B 27.99B 23.8B 22.27B 20.92B 38.54B 2,539B 42.1B 260B 100B 1,195B 105B 103B 4,346B P/E ratio 2025 *
52.7x
P/E ratio 2026 * 34.9x
Enterprise value 42.1B 28.68M 24.39M 22.82M 21.43M 39.49M 2.6B 43.14M 266M 103M 1.22B 108M 105M 4.45B EV / Sales 2025 *
10.2x
EV / Sales 2026 * 8.52x
Free-Float
70.87%
Yield 2025 *
0.39%
Yield 2026 * 0.42%
More valuation ratios * Estimated data
Dynamic Chart

Last Transcript: Celltrion, Inc.

1 day+0.54%
1 week+0.37%
Current month+1.19%
1 month-4.23%
3 months+10.47%
6 months+16.79%
Current year+4.17%
More quotes
1 week 184,100
Extreme 184100
192,100
1 month 180,000
Extreme 180000
199,100
Current year 144,615.38
Extreme 144615.3846
203,500
1 year 144,615.38
Extreme 144615.3846
203,500
3 years 119,963.37
Extreme 119963.37
220,695.97
5 years 119,963.37
Extreme 119963.37
336,673.13
10 years 54,657.79
Extreme 54657.7878
341,497.26
More quotes
Manager TitleAgeSince
Chief Executive Officer - 2015-03-19
Director of Finance/CFO 50 -
Compliance Officer 43 -
Director TitleAgeSince
Chairman 68 -
Director/Board Member 67 2008-07-16
Director/Board Member 67 2008-07-16
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+0.54%+0.37%+6.04%+18.82% 27.99B
-0.48%-3.73%-4.47%+15.87% 46.18B
+0.62%+0.03%+12.34%+7.30% 38.08B
-2.63%-4.85%+73.22%+49.42% 34.38B
+0.22%+1.81%+61.63%+171.67% 15.75B
+0.10%-1.32%+75.52%+229.03% 15.27B
-1.18%+1.25%-11.42%-3.39% 14.08B
-3.26%+2.95%+64.19%+79.18% 13.03B
-1.31%-2.15%+117.86%+108.80% 12.92B
-2.75%-10.86%+67.49% - 12.22B
Average -1.07%-1.75%+46.24%+75.19% 22.99B
Weighted average by Cap. -0.84%-2.04%+35.22%+54.33%
See all sector performances

Financials

2025 *2026 *
Net sales 4,140B 2.82B 2.4B 2.24B 2.11B 3.88B 256B 4.24B 26.16B 10.11B 120B 10.58B 10.36B 438B 4,933B 3.36B 2.86B 2.67B 2.51B 4.63B 305B 5.06B 31.17B 12.05B 143B 12.61B 12.34B 522B
Net income 817B 556M 473M 443M 416M 766M 50.47B 837M 5.16B 1.99B 23.76B 2.09B 2.04B 86.39B 1,229B 837M 712M 666M 626M 1.15B 75.95B 1.26B 7.77B 3B 35.75B 3.14B 3.08B 130B
Net Debt 1,013B 690M 587M 549M 515M 950M 62.57B 1.04B 6.4B 2.47B 29.45B 2.59B 2.53B 107B 921B 627M 533M 499M 469M 864M 56.91B 944M 5.82B 2.25B 26.79B 2.35B 2.3B 97.41B
More financial data * Estimated data
Logo Celltrion, Inc.
Celltrion Inc is a Korea-based company mainly engaged in the production and sale of bio pharmaceuticals. The Company operates its business through two segments. The Bio Pharmaceutical segment produces and sells protein therapeutics such as anticancer drugs. In addition, this Segment develops monoclonal antibodies(mABs) that are used to treat chronic autoimmune diseases such as arthritis and severe diseases such as breast and colon cancer. The Chemical Pharmaceutical segment is mainly engaged in the manufacture and sale of chemical drugs. In addition, the Segment sells bio drugs, and provides services such as data analysis. The Company's main products include liver and bowel medicines and other generics. The main products sold by the Company include autoimmune disease treatment agents, anti-malignant tumor drugs and other products. The Company sells its products in domestic and overseas markets such as Europe and the United States.
Employees
2,680
More about the company
Date Price Change Volume
25-12-15 187,800.00 +0.54% 517,365
25-12-12 186,800.00 +0.05% 462,458
25-12-11 186,700.00 +0.54% 940,315
25-12-10 185,700.00 -0.85% 307,749
25-12-09 187,300.00 +0.11% 348,992

End-of-day quote Korea S.E., December 14, 2025

More quotes
Trader
Investor
Global
Quality
ESG MSCI
A
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
187,800.00KRW
Average target price
223,458.07KRW
Spread / Average Target
+18.99%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. A068270 Stock